FDA Warning Letter — Rubicon Oasis

Case 509925 — FEI 3012902431

The FDA took a Warning Letter action against Rubicon Oasis on Nov 3, 2016 (Rubicon, WI). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Rubicon Oasis
Date
Nov 3, 2016
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Rubicon, WI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.